The abstract is read at the publisher; the summary is JClub's.
Loss of Lats1 in a zebrafish melanoma model is linked to reduced tumour-free survival in BRAF-mutant disease and a more invasive phenotype in NRAS-mutant disease.
- Why it matters: Melanoma survival stays poor after metastasis, and NRAS-mutant patients lack targeted options; resistance mechanisms and MST2/Hippo roles remain unclear.
- What they did: The study created a lats1 knockout zebrafish melanoma model driven by BRAF or NRAS mutations, then integrated transcriptomics and proteomics to map Lats1-mediated pathways, including immune-response programs.
- The result: Patient-data validation supports an immune-evasive phenotype tied to decreased LATS1 expression in BRAF-mutant melanoma, and LATS1 loss in NRAS-mutant melanoma patients alters key DNA damage repair gene expression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.